No black box warning on record for Fenofibrate

As of the latest FDA labeling reviewed, Fenofibrate (FENOFIBRATE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Fenofibrate medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Hepatotoxicity : Serious drug-induced liver injury, including liver transplantation and death, has been reported with fenofibrate. Monitor patient's liver function, including serum ALT, AST, and total bilirubin, atbaseline and periodically for the duration of therapy. Discontinue if signs or symptoms of liver injury develop or if elevated enzyme levels persist ( 5.2 ). M

No black box warning on record for Fenofibrate

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Hepatotoxicity : Serious drug-induced liver injury, including liver transplantation and death, has been reported with fenofibrate. Monitor patient's liver function, including serum ALT, AST, and total bilirubin, atbaseline and periodically for the duration of therapy. Discontinue if signs or symptoms of liver injury develop or if elevated enzyme levels persist ( 5.2 ). M

Fenofibrate Black Box Warning

No black box warning on record for Fenofibrate

Other warnings & precautions

Fenofibrate Black Box Warning

No black box warning on record for Fenofibrate

Other warnings & precautions